The Journal of Immunology, Vol 144, Issue 11 4269-4274, Copyright © 1990 by American Association of Immunologists

ARTICLES

Inhibition of factor I by diisopropylfluorophosphate. Evidence of conformational changes in factor I induced by C3b and additional studies on the specificity of factor I

KN Ekdahl, UR Nilsson and B Nilsson
Department of Clinical Immunology and Transfusion Medicine, University Hospital, Uppsala, Sweden.

The factor I-mediated cleavage of C3b, using factor H as a cofactor was completely inhibited by diisopropylfluorophosphate (DFP) when factor I and C3b were incubated with DFP before the addition of factor H. Inhibition, although to a lesser degree, was observed when factor H was present during DFP-exposure. No inhibition in factor I activity was seen when factor I and H were incubated with DFP either alone or together. It was also demonstrated that the 38-kDa subunit of factor I bound radiolabeled DFP when factor I and C3b together were exposed to DFP. These observations suggest that factor I interacts with C3b in a manner that exposes its catalytic site to DFP, an interaction that is independent of factor H. The inhibitory effect by DFP on factor I led us to further investigate the factor I cleavage products of iC3b, inasmuch as previous reports were ambiguous as to whether digestion occurs in the presence of DFP. Digestion of C3b bound to activated thiol Sepharose (ATS-C3b) in the presence of factor H at low pH and ionic strength and in serum by complement activation produced C3d,g- like fragments with apparent molecular mass of 41 and 43 kDa. These fragments were shown to have three different N-terminal and two different C-terminal ends. The major fragments had N-terminal sequences starting with Glu933, as shown by sequence determination. Traces of fragments extending beyond this point were also found, shown by Western blot analysis using a panel of mAb previously shown to bind to epitopes exposed within a region of C3 spanning residues 929 to 943, as well as a shorter fragment starting with Glu938. When digestion of C3b is carried out in the presence of DFP, the factor I level necessary for digestion is elevated and may explain how the first two cleavages producing iC3b but not the following giving C3d,g, can occur. The finding of several factor I cleavage sites in the C3d,g region of C3 demonstrates that factor I has a broad specificity, mainly for arginyl bonds. It has also been shown to digest a lysyl bond exposed in ATS- bound C3b.

This article has been cited by other articles:

				B. A. Zabel, S. J. Allen, P. Kulig, J. A. Allen, J. Cichy, T. M. Handel, and E. C. Butcher Chemerin Activation by Serine Proteases of the Coagulation, Fibrinolytic, and Inflammatory Cascades J. Biol. Chem., October 14, 2005; 280(41): 34661 - 34666. [Abstract] [Full Text] [PDF]

				S. A. Tsiftsoglou and R. B. Sim Human Complement Factor I Does Not Require Cofactors for Cleavage of Synthetic Substrates J. Immunol., July 1, 2004; 173(1): 367 - 375. [Abstract] [Full Text] [PDF]

				A. M. Blom, B. O. Villoutreix, and B. Dahlback Mutations in {alpha}-Chain of C4BP That Selectively Affect Its Factor I Cofactor Function J. Biol. Chem., October 31, 2003; 278(44): 43437 - 43442. [Abstract] [Full Text] [PDF]

				O. B. Spiller, D. J. Blackbourn, L. Mark, D. G. Proctor, and A. M. Blom Functional Activity of the Complement Regulator Encoded by Kaposi's Sarcoma-associated Herpesvirus J. Biol. Chem., March 7, 2003; 278(11): 9283 - 9289. [Abstract] [Full Text] [PDF]